Sönmez Mehmet Giray, Kozanhan Betül
Department of Urology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey.
Ginekol Pol. 2017;88(2):61-67. doi: 10.5603/GP.a2017.0013.
Interstitial Cystitis/Bladder Pain syndrome (IC/BPS) is a considerable issue in urology and gynecology and unfortunately, the treatment options recommended are not fully efficient. Therefore, in this study we aimed to determine the effectiveness of acupuncture treatment in patients with refractory IC/BPS.
12 refractory IC/BPS female patients received ten sessions of acupuncture twice a week. The visual analog score (VAS), interstitial cystitis symptom index (ICSI), interstitial cystitis problem index (ICPI), O'Leary-Saint symptom score (OSS), Patient Health Questionnaire (PHQ9), Pelvic pain and urgency & frequency patient symptom scale tests (PUF) and maximum voided volume (MVV) was completed in 1st, 3rd, 6th and 12th months following the treatment.
There was a statistically significant decrease in all of the scores evaluated at first month compared with the baseline. While the change in VAS score in 1, 3, 6 and 12th months were found statistically significant, measurements of ICSI, OSS and PUF scores and MVV values in the 6th and 12th months and ICPI and PHQ scores in the 12th month were not found statistically significant compared to the pre-treatment period. Response to treatment for the first three months after acupuncture application was (100%), but this ratio was measured as 33.3% (4/12) in the sixth month and 16.6% in the 12th month (2/12).
The results of this study suggest that acupuncture appears to be an effective, useful, non-invasive method in IC/BPS patients. It can be used as an appropriate treatment method not only in refractory but also in IC patients since it is rather advantageous compared to other treating agents.
间质性膀胱炎/膀胱疼痛综合征(IC/BPS)是泌尿外科和妇科领域的一个重要问题,遗憾的是,推荐的治疗方案并非完全有效。因此,在本研究中,我们旨在确定针刺治疗难治性IC/BPS患者的有效性。
12例难治性IC/BPS女性患者接受每周两次、共十次的针刺治疗。在治疗后的第1、3、6和12个月完成视觉模拟评分(VAS)、间质性膀胱炎症状指数(ICSI)、间质性膀胱炎问题指数(ICPI)、奥利里-圣症状评分(OSS)、患者健康问卷(PHQ9)、盆腔疼痛及尿急尿频患者症状量表测试(PUF)和最大排尿量(MVV)。
与基线相比,第一个月评估的所有分数均有统计学意义的下降。虽然第1、3、6和12个月的VAS评分变化具有统计学意义,但与治疗前期相比,第6和12个月的ICSI、OSS和PUF评分以及MVV值以及第12个月的ICPI和PHQ评分无统计学意义。针刺治疗后前三个月的治疗反应率为100%,但在第六个月该比例为33.3%(4/12),在第12个月为16.6%(2/12)。
本研究结果表明,针刺似乎是治疗IC/BPS患者的一种有效、有用的非侵入性方法。与其他治疗药物相比,它不仅可作为难治性IC患者的合适治疗方法,也可用于IC患者。